Galecto Competitors and Similar CompaniesClear all
Supernus Pharmaceuticals's competitors and similar companies include GlycoMimetics.
 Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. | |
Founding Date | Founding Date 2005 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Rockville, US HQ | Locations Rockville, US HQ |
Employees | Employees 6527% increase | Employees 5025% increase |
Valuation ($) | Valuation ($) 1.9 b | Valuation ($) 31.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $719m (FY, 2025) | Revenue (est.) $10.8m (FY, 2025) |
Net income | Net income ($38.6m) (FY, 2025) | Net income ($153.9m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 69.5m | Total funding raised $ 101.8m |
For sources of this data, please see the company profile
View Company Profiles
GlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View company